The semaglutide impurity des-9-Asp-SMT is a structurally related impurity that may be produced during the synthesis or storage of semaglutide. As a GLP-1 receptor agonist drug, semaglutide is composed of 31 amino acids and is mainly used to treat type 2 diabetes and obesity. This impurity is different from the drug molecule with a complete structure due to the lack of the aspartic acid (Asp) residue at the 9th position, which may affect the purity and bioavailability of the drug. During the drug production process, this impurity needs to be strictly controlled and limited to ensure the safety and efficacy of the drug.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Asp-Val-Arg-Arg-Arg-Arg-Arg-Arg-Gly-CONH2 |
Single letter sequence |
HHAEGTFTSVSSYLEGQAKKEFIAWLVKGDVRRAARRRRG-NH2 |
Molecular formula |
C183H284N51O56S |
Molecular weight |
4034.16 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |